2018 Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Team Science Awards

Targeting BAP1-dependent alterations in metastatic uveal melanoma

The Helman Family-MRA Team Science Award, 2018-2021

  • Andrew Aplin, Thomas Jefferson University

  • Emily Bernstein, Icahn School of Medicine at Mount Sinai

  • J. William Harbour, Sylvester Comprehensive Cancer Center/University of Miami Health Systems

  • Young Investigator: Marlana Orloff, Thomas Jefferson University

Diet, mental health, and the microbiome in response to immunotherapy

MRA Team Science Award, collaboratively funded by University of Texas MD Anderson Cancer Center, 2018-2021

  • Lorenzo Cohen, University of Texas MD Anderson Cancer Center

  • Jennifer Wargo, University of Texas MD Anderson Cancer Center

  • Young Investigator: Jennifer McQuade, University of Texas MD Anderson Cancer Center

Autophagy in the tumor microenvironment as a target for drug development

The Anna-Maria and Stephen Kellen Foundation-MRA Team Science Award, 2018-2021

  • Hilary Coller, University of California, Los Angeles

  • Beatrice Knudsen, Cedars-Sinai Medical Center

  • Lili Yang, University of California, Los Angeles

  • Young Investigator: Claudio Scafoglio, University of California, Los Angeles

Telomere crisis in acral melanoma: Diagnostic and prognostic potentials

The Black Family-MRA Team Science Award, 2018-2021

  • Titia de Lange, The Rockefeller University

  • Marcin Imielinski, Joan & Sanford I. Weill Medical College of Cornell University

  • Young Investigator: John Maciejowski, Memorial Sloan Kettering Cancer Center

Commensal microbiota and anti-PD-1 efficacy

MRA Team Science Award, collaboratively funded by The University of Chicago, 2018-2021

  • Thomas Gajewski, The University of Chicago

  • Jason Luke, The University of Chicago

  • Cathryn Nagler, The University of Chicago

  • Young Investigator: Riyue Bao, The University of Chicago

Patient focused therapy for acral melanoma

The Sokoloff Family-MRA Team Science Award, with collaborative funding from Memorial Sloan Kettering Cancer Center, 2018-2021

  • Ruth Halaban, Yale University

  • Charlotte Ariyan, Memorial Sloan Kettering Cancer Center

  • Alfred Bothwell, Yale University

  • Jian Cao, Yale University

  • Neal Rosen, Memorial Sloan Kettering Cancer Center

  • Richard White, Memorial Sloan Kettering Cancer Center

  • Jedd Wolchok, Memorial Sloan Kettering Cancer Center

  • Qin Yan, Yale University

  • Young Investigator: Gauri Panse, Yale University

Identifying genetic dependencies in rare forms of melanoma

MRA Team Science Award, 2018-2021

  • Nicholas Hayward, Queensland Institute of Medical Research

  • Francisca Vazquez, Broad Institute

  • Young Investigator: Ken Dutton-Regester, Queensland Institute of Medical Research

Prognostic and functional role of altered circular RNAs in melanoma

Leveraged Finance Fights Melanoma-MRA Team Science Award, 2018-2021

  • Eva Hernando, New York University School of Medicine

  • Ernesto Guccione, Icahn School of Medicine at Mount Sinai

  • Edward and Julie Minskoff – Young Investigator: Melissa Wilson, New York University School of Medicine

Next-generation neoantigen-targeting peptide vaccines for melanoma patients

BJ’s Wholesale Club-MRA Team Science Award, 2018-2021

  • Patrick Ott, Dana-Farber Cancer Institute

  • Bradley Pentelute, Massachusetts Institute of Technology

  • Catherine Wu, Dana-Farber Cancer Institute

  • Young Investigator: Osama Rahma, Dana-Farber Cancer Institute

Regulating telomerase & telomere homeostasis in acral melanoma development

MRA Team Science Award, collaboratively funded by the research institutions, 2018-2021

  • Gavin Robertson, The Pennsylvania State University College of Medicine

  • Jiyue Zhu, Washington State University

  • Young Investigator: De Cheng, Washington State University

  • Young Investigator: Shobhan Gaddameedhi, Washington State University

  • Young Investigator: Raghavendra Gowda, The Pennsylvania State University College of Medicine

Defining and targeting driver events in acral melanoma

U.S. Trust-MRA Team Science Award, 2018-2021

  • Keiran Smalley, H. Lee Moffitt Cancer Center & Research Institute

  • Yian Chen, H. Lee Moffitt Cancer Center & Research Institute

  • John Koomen, H. Lee Moffitt Cancer Center & Research Institute

  • Jane Messina, H. Lee Moffitt Cancer Center & Research Institute

  • Jamie Teer, H. Lee Moffitt Cancer Center & Research Institute

  • Young Investigator, Florian Karreth, H. Lee Moffitt Cancer Center & Research Institute

Directing adaptive immune responses to non-polymorphic MHCs in melanoma

MRA Team Science Award, collaboratively funded by Massachusetts Institute of Technology, 2018-2021

  • Forest White, Massachusetts Institute of Technology-Koch Institute for Integrative Cancer Research

  • Dane Wittrup, Massachusetts Institute of Technology

  • Young Investigator: Michael Birnbaum, Massachusetts Institute of Technology-Koch Institute for Integrative Cancer Research

  • Young Investigator: Stefani Spranger, Massachusetts Institute of Technology-Koch Institute for Integrative Cancer Research

DAMPening immunotherapy adverse events in melanoma

MRA Team Science Award, collaboratively funded by the research institutions, 2018-2021

  • Pan Zheng, University of Maryland, Baltimore

  • Yang Liu, University of Maryland, Baltimore

  • Young Investigator: Siwen Hu-Lieskovan, The University of California, Los Angele

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

Login